Physician profile
Peter Surace
NPI 1093193591
$146,491.93
in general payments reported to CMS, 2019-2025
10 companies · $110K in 2025
The $110K reported for 2025 was more than what 93% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13K · 2021: $16K · 2022: $2,133 · 2023: $1,373 · 2024: $4,235 · 2025: $110K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $90K · Travel and Lodging: $20K · Food and Beverage: $6,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $89,775.00 |
| Travel and Lodging | $19,702.42 |
| Food and Beverage | $6,389.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $116,614.16 | 2021-2025 | Mako, Restoration, Triathlon |
| Smith+Nephew, INC. | $27,162.03 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $1,532.32 | 2022-2025 | Rosa, Persona, Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $238.35 | 2022-2024 | Na, Va-Lcp, Tfn-Advance |
| Uoc USA INC | $234.02 | 2022 | |
| Medtronic, INC. | $230.44 | 2022-2024 | Aquamantys(Tm) |
| Biocomposites INC | $210.87 | 2023-2024 | Stimulan |
| Onkos Surgical, INC. | $124.60 | 2025 | Eleos Limb Salvage System |
| Ethicon US, LLC | $119.71 | 2022-2023 | Stratafix |
| Medical Device Business Services, INC. | $25.43 | 2024 | Attune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Surace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.